Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperoxia effects on organ dysfunction and outcome in critically ill patients with SIRS
2014-003468-19Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxygen in Systemic Inflammatory Response Syndrome (SIRS) and critical illness (2 arms), sponsored by VU University Medical Center. Primary endpoint: Cumulative Δ SOFA score (first 14 days). Started Jan 2015; status: active.
02
Drugs
oxygen
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)critical illness
Beyond the preview
Go deeper on 2014-003468-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003468-19.